Skip to main content
Log in

Prevention of adverse events would be cost saving in Tuscany

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 euros

Reference

  • Convertino I, et al. Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis. Drug Safety : 1 Oct 2018. Available from: URL: https://doi.org/10.1007/s40264-018-0737-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prevention of adverse events would be cost saving in Tuscany. PharmacoEcon Outcomes News 814, 21 (2018). https://doi.org/10.1007/s40274-018-5364-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5364-6

Navigation